TrackU: An Educational Self-tracking Tool for Identification of SARS-CoV-2 Risk Transmission
Study Details
Study Description
Brief Summary
One way to empower a community, in epidemic control issues, is to know the first-hand screening tools. There are no evaluations of these home-use tools from the perspective of patient and citizen empowerment and participation. The main objective of this study is to analyze whether a self-tracking and self-tracing tool, developed in a participatory way, increases the risk identification of the disease and the empowerment in terms of risk management of transmission by the participants.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Intervention : Educational tool self-tracking educational tool (diary) |
Other: Track U
Track U diary
|
No Intervention: Control
|
Outcome Measures
Primary Outcome Measures
- Risk identification of SARS-CoV 2 transmission [17 days]
Risk identification of SARS-CoV 2 transmission
Secondary Outcome Measures
- Empowerment in SARS-CoV 2 transmission [17 days]
Empowerment in SARS-CoV 2 transmission
Eligibility Criteria
Criteria
Inclusion Criteria:
Fluent in Catalan or Spanish, Resident in Catalonia, Signs informed consent, Commitment to use the tool if he/she gets in intervention group.
Exclusion Criteria:
Language barrier and other conditions that do not allow self-completion of the survey Be a COVID case or contact at the time of recruitment.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hospital Clinic de Barcelona | Barcelona | Spain | 08036 |
Sponsors and Collaborators
- Hospital Clinic of Barcelona
- Escoles Universitaries Gimbernat
- University of Barcelona
- Barcelona Institute for Global Health
- Universitat Politècnica de Catalunya
- Universitat Oberta de Catalunya
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HCB/2021/1054